ANAB vs JAZZ · rev $234.6M vs P/E 1988, rev $2.28B
AnaptysBio Inc (ANAB) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported ANAB revenue for 2025-12-31 was $234.6M. Net income was -$13.2M. Revenue was up 157.0% from 2024-12-31 to 2025-12-31. ANAB currently screens at market cap $1.62B.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
ANAB currently screens at market cap $1.62B. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the ANAB and JAZZ stock pages for the full models.
Not investment advice.